• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体在肝损伤、再生和移植中的作用。

The Role of Complement in Liver Injury, Regeneration, and Transplantation.

机构信息

Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway.

Department of Gastroenterological Surgery, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

出版信息

Hepatology. 2019 Aug;70(2):725-736. doi: 10.1002/hep.30508. Epub 2019 Jul 15.

DOI:10.1002/hep.30508
PMID:30653682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6771474/
Abstract

The liver is both an immunologically complex and a privileged organ. The innate immune system is a central player, in which the complement system emerges as a pivotal part of liver homeostasis, immune responses, and crosstalk with other effector systems in both innate and adaptive immunity. The liver produces the majority of the complement proteins and is the home of important immune cells such as Kupffer cells. Liver immune responses are delicately tuned between tolerance to many antigens flowing in from the alimentary tract, a tolerance that likely makes the liver less prone to rejection than other solid organ transplants, and reaction to local injury, systemic inflammation, and regeneration. Notably, complement is a double-edged sword as activation is detrimental by inducing inflammatory tissue damage in, for example, ischemia-reperfusion injury and transplant rejection yet is beneficial for liver tissue regeneration. Therapeutic complement inhibition is rapidly developing for routine clinical treatment of several diseases. In the liver, targeted inhibition of damaged tissue may be a rational and promising approach to avoid further tissue destruction and simultaneously preserve beneficial effects of complement in areas of proliferation. Here, we argue that complement is a key system to manipulate in the liver in several clinical settings, including liver injury and regeneration after major surgery and preservation of the organ during transplantation.

摘要

肝脏既是一个免疫复杂的器官,也是一个具有特权的器官。先天免疫系统是一个核心参与者,其中补体系统作为肝脏内稳态、免疫反应以及与先天和适应性免疫中的其他效应系统相互作用的关键部分出现。肝脏产生大部分补体蛋白,也是重要免疫细胞如枯否细胞的所在地。肝脏免疫反应在耐受来自肠道的许多抗原和对局部损伤、全身炎症和再生的反应之间被精细地调节。值得注意的是,补体是一把双刃剑,因为其激活会通过诱导缺血再灌注损伤和移植排斥等炎症性组织损伤而产生有害作用,但对肝脏组织再生有益。针对补体的治疗性抑制正在迅速发展,以常规治疗几种疾病。在肝脏中,针对受损组织的靶向抑制可能是一种合理且有前途的方法,可以避免进一步的组织破坏,同时保留补体在增殖区域的有益作用。在这里,我们认为补体是几个临床环境中需要操纵的关键系统,包括大手术后的肝脏损伤和再生以及移植过程中对器官的保存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f653/6771474/6833218f3e06/HEP-70-725-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f653/6771474/0c4d3f5bd650/HEP-70-725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f653/6771474/6308d3ce5b02/HEP-70-725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f653/6771474/6833218f3e06/HEP-70-725-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f653/6771474/0c4d3f5bd650/HEP-70-725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f653/6771474/6308d3ce5b02/HEP-70-725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f653/6771474/6833218f3e06/HEP-70-725-g003.jpg

相似文献

1
The Role of Complement in Liver Injury, Regeneration, and Transplantation.补体在肝损伤、再生和移植中的作用。
Hepatology. 2019 Aug;70(2):725-736. doi: 10.1002/hep.30508. Epub 2019 Jul 15.
2
Complement and Transplantation: From New Mechanisms to Potential Biomarkers and Novel Treatment Strategies.补体与移植:从新机制到潜在生物标志物及新型治疗策略
Clin Lab Med. 2019 Mar;39(1):31-43. doi: 10.1016/j.cll.2018.10.004. Epub 2018 Dec 20.
3
The Role of Complement in Organ Transplantation.补体在器官移植中的作用。
Front Immunol. 2019 Oct 4;10:2380. doi: 10.3389/fimmu.2019.02380. eCollection 2019.
4
[Sterile inflammatory response to ischemia-reperfusion injury: immediate and long term consequences on graft function].[对缺血再灌注损伤的无菌性炎症反应:对移植物功能的即时和长期影响]
Bull Acad Natl Med. 2011 Apr-May;195(4-5):847-59; discussion 859.
5
Role of complement and perspectives for intervention in transplantation.补体在移植中的作用及干预策略。
Immunobiology. 2013 May;218(5):817-27. doi: 10.1016/j.imbio.2012.09.002. Epub 2012 Oct 4.
6
Role of NK, NKT cells and macrophages in liver transplantation.自然杀伤细胞、自然杀伤T细胞和巨噬细胞在肝移植中的作用。
World J Gastroenterol. 2016 Jul 21;22(27):6135-44. doi: 10.3748/wjg.v22.i27.6135.
7
Control of innate immunological mechanisms as a route to drug minimization.控制先天免疫机制作为减少药物使用的途径。
Curr Opin Organ Transplant. 2014 Aug;19(4):342-7. doi: 10.1097/MOT.0000000000000094.
8
Role of the complement system in rejection.补体系统在排斥反应中的作用。
Curr Opin Immunol. 2003 Oct;15(5):487-92. doi: 10.1016/s0952-7915(03)00100-6.
9
Molecular pathways of regeneration and repair after liver transplantation.肝移植后再生与修复的分子途径。
World J Surg. 2002 Jul;26(7):831-7. doi: 10.1007/s00268-002-4060-6. Epub 2002 Apr 15.
10
Allograft rejection: effect of local synthesis of complement.同种异体移植排斥反应:补体局部合成的影响
Springer Semin Immunopathol. 2005 Nov;27(3):332-44. doi: 10.1007/s00281-005-0005-0. Epub 2005 Nov 11.

引用本文的文献

1
The complement system in human pregnancy and preeclampsia.人类妊娠和子痫前期中的补体系统。
Front Immunol. 2025 Aug 19;16:1617140. doi: 10.3389/fimmu.2025.1617140. eCollection 2025.
2
Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment.用于监测慢性乙型肝炎治疗患者肝纤维化消退的血清蛋白质组学特征分析
Nat Commun. 2025 Aug 19;16(1):7714. doi: 10.1038/s41467-025-63006-z.
3
Redefining the Immunobiology of Organ Transplantation for New Clinical Horizons.为新的临床前景重新定义器官移植的免疫生物学。

本文引用的文献

1
Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1.补体 C1q 通过激活盘状结构域受体 1 促进肝细胞肿瘤的进展。
Sci Rep. 2018 Mar 20;8(1):4908. doi: 10.1038/s41598-018-23240-6.
2
Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌的流行
World J Clin Oncol. 2017 Dec 10;8(6):429-436. doi: 10.5306/wjco.v8.i6.429.
3
Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of sepsis.
Scand J Immunol. 2025 Aug;102(2):e70045. doi: 10.1111/sji.70045.
4
Exercise-related immune gene signature for hepatocellular carcinoma: machine learning and multi-omics analysis.肝细胞癌的运动相关免疫基因特征:机器学习与多组学分析
Front Immunol. 2025 Jun 20;16:1606711. doi: 10.3389/fimmu.2025.1606711. eCollection 2025.
5
Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells.肝脏内稳态与疾病中的炎症和免疫:肝细胞、非实质细胞与免疫细胞的关联
Cell Mol Immunol. 2025 Jul 1. doi: 10.1038/s41423-025-01313-7.
6
Diclofenac Immune-Mediated Hepatitis: Identification of Innate and Adaptive Immune Responses at Clinically Relevant Doses.双氯芬酸免疫介导性肝炎:在临床相关剂量下对固有免疫和适应性免疫反应的鉴定
Int J Mol Sci. 2025 Jun 19;26(12):5899. doi: 10.3390/ijms26125899.
7
Potential common mechanisms between primary Sjögren's syndrome and Hashimoto's thyroiditis: a public databases-based study.原发性干燥综合征与桥本甲状腺炎之间潜在的共同机制:一项基于公共数据库的研究
Front Genet. 2025 Apr 29;16:1520332. doi: 10.3389/fgene.2025.1520332. eCollection 2025.
8
Research progress on the roles of complement in liver injury.补体在肝损伤中作用的研究进展
World J Hepatol. 2025 Mar 27;17(3):103839. doi: 10.4254/wjh.v17.i3.103839.
9
The effect of TIM1 Breg cells in liver ischemia-reperfusion injury.TIM1调节性B细胞在肝脏缺血再灌注损伤中的作用。
Cell Death Dis. 2025 Mar 12;16(1):171. doi: 10.1038/s41419-025-07446-x.
10
Comprehensive analysis of immunogenic cell death-related genes in liver ischemia-reperfusion injury.肝脏缺血再灌注损伤中免疫原性细胞死亡相关基因的综合分析
Front Immunol. 2025 Feb 17;16:1545185. doi: 10.3389/fimmu.2025.1545185. eCollection 2025.
在狒狒脓毒症模型中,抑制补体C5可预防器官衰竭并降低死亡率。
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6390-E6399. doi: 10.1073/pnas.1706818114. Epub 2017 Jul 18.
4
Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.固有免疫调节与肝脏缺血再灌注损伤
Transplantation. 2016 Dec;100(12):2601-2610. doi: 10.1097/TP.0000000000001411.
5
Evolution of the complement system: from defense of the single cell to guardian of the intravascular space.补体系统的进化:从单细胞防御到血管内空间守护者。
Immunol Rev. 2016 Nov;274(1):9-15. doi: 10.1111/imr.12474.
6
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets.补体和Toll样受体的双重抑制作为治疗炎症性疾病的新方法——C3或C5与CD14一起成为有前景的靶点。
J Leukoc Biol. 2017 Jan;101(1):193-204. doi: 10.1189/jlb.3VMR0316-132R. Epub 2016 Aug 31.
7
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.2016 年肝移植病理学班夫工作组综合更新:抗体介导排斥反应的引入。
Am J Transplant. 2016 Oct;16(10):2816-2835. doi: 10.1111/ajt.13909. Epub 2016 Jul 14.
8
IL-6 pathway in the liver: From physiopathology to therapy.肝脏中的 IL-6 通路:从病理生理学到治疗。
J Hepatol. 2016 Jun;64(6):1403-15. doi: 10.1016/j.jhep.2016.02.004. Epub 2016 Feb 8.
9
Monitoring efficiency of humoral rejection episode therapy in liver transplantation: any role for complement binding Luminex Single Antigen assays?肝移植中体液排斥反应治疗的监测效率:补体结合Luminex单抗原检测有何作用?
Transpl Immunol. 2016 Mar;35:23-8. doi: 10.1016/j.trim.2016.01.007. Epub 2016 Feb 1.
10
The Complement System and Antibody-Mediated Transplant Rejection.补体系统与抗体介导的移植排斥反应
J Immunol. 2015 Dec 15;195(12):5525-31. doi: 10.4049/jimmunol.1501686.